Physician profile
Ray E Johnson
NPI 1124046545
$1,313.89
in general payments reported to CMS, 2019-2025
18 companies · $229 in 2025
The $229 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $484 · 2020: $22.00 · 2021: $33.72 · 2022: $185 · 2023: $177 · 2024: $182 · 2025: $229.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $588.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $588.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $232.93 | 2019-2023 | Watchman Access System |
| Pfizer INC. | $191.74 | 2019-2025 | |
| E.R. Squibb & Sons, L.L.C. | $175.97 | 2022-2025 | Camzyos, Eliquis |
| Janssen Pharmaceuticals, INC | $150.24 | 2019-2024 | Xarelto |
| Inari Medical, INC. | $109.33 | 2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Philips North America LLC | $85.87 | 2022-2025 | Ecc Solutions |
| Medtronic, INC. | $58.11 | 2022-2025 | Corevalve Evolut R |
| Novartis Pharmaceuticals Corporation | $58.05 | 2019-2025 | |
| Angiodynamics, INC. | $50.72 | 2019 | |
| Bardy Diagnostics, INC. | $32.00 | 2019-2020 | |
| Astrazeneca Pharmaceuticals Lp | $28.03 | 2021-2022 | |
| Inspire Medical Systems, INC. | $26.64 | 2024 | Inspire |
| Vital Connect, INC | $22.11 | 2022 | |
| Cvrx, INC. | $20.65 | 2025 | Barostim Neo System |
| Regeneron Healthcare Solutions, INC. | $20.11 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kiniksa Pharmaceuticals International, Plc | $20.04 | 2024 | Arcalyst |
| Lexicon Pharmaceuticals, INC. | $16.50 | 2023 | Inpefa |
| Irhythm Technologies, INC. | $14.85 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ray Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.